AATD: Clinical Trials

7 trials for AATD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1
Phase 23Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow this condition Literature Review of AATD trials Research Report on AATD

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Safety and Efficacy of Prime Editing (PM647a) in Participants With Alpha-1 Antitrypsin Deficiency
PM647a - Alpha-1 Antitrypsin Deficiency, Alpha-1 Antitrypsin Deficiency-associated Lung Disease
Phase 1 / Phase 2Not yet recruitingPrime Medicine, Inc.542026-10-012026-10-21
A Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110
KRRO-110 - Alpha-1 Anti-trypsin Deficiency, AATD
Phase 1 / Phase 2TerminatedKorro Bio, Inc.422025-01-132026-04-17
NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
Biological NTLA-3001 - Lung Disease, Pulmonary Disease
Phase 1 / Phase 2WithdrawnIntellia Therapeutics2024-11-202025-01-17
Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
INBRX-101/rhAAT-Fc - Alpha-1 Antitrypsin Deficiency, AATD
Phase 1CompletedInhibrx Biosciences, Inc312019-07-192022-09-13
Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)
Abdominal ultrasound, History and physical, Intravenous catheter - Liver Fibrosis, Alpha-1 Antitrypsin Deficiency
CompletedUniversity of Florida1092013-10-012023-08-21
Genomic Research in Alpha-1 Antitrypsin Deficiency
Alpha 1 Antitrypsin Deficiency, AATD
CompletedUniversity of Pittsburgh1402013-05-012016-01-12
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
History and physical exam., Blood draw., Pulmonary function testing. - Alpha-1 Antitrypsin Deficiency, AAT Deficiency
RecruitingUniversity of Florida2202007-08-092025-11-06

Narrower conditions

alpha 1-Antitrypsin Deficiency (7)  ·  Cystic Fibrosis (1)  ·  Fibrosis (1)  ·  Liver Cirrhosis (1)  ·  Lung Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Digestive System Diseases (7)  ·  Emphysema (7)  ·  Genetic Diseases, Inborn (7)  ·  Liver Diseases (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Respiratory Tract Diseases (7)  ·  Subcutaneous Emphysema (7)  ·  Lung Diseases (6)  ·  Infant, Newborn, Diseases (1)  ·  Pancreatic Diseases (1)

Interventions

Blood Specimen Collection (2)  ·  Health Records, Personal (2)  ·  Phlebotomy (2)  ·  Restraint, Physical (2)  ·  Acetaminophen (1)  ·  Albuterol (1)  ·  Biopsy (1)  ·  Fentanyl (1)  ·  Lidocaine (1)  ·  Lorazepam (1)  ·  Midazolam (1)  ·  Ondansetron (1)  ·  Procaterol (1)  ·  Respiratory Physiological Phenomena (1)  ·  Surveys and Questionnaires (1)

Sponsors

University of Florida (2)  ·  Inhibrx Biosciences, Inc (1)  ·  Intellia Therapeutics (1)  ·  Korro Bio, Inc. (1)  ·  Prime Medicine, Inc. (1)  ·  University of Pittsburgh (1)

Countries

United States (4)  ·  New Zealand (3)  ·  Australia (1)  ·  United Kingdom (1)

Top investigators

Karina Serban, MD (1)  ·  Mark Brantly, MD (1)  ·  Michael Becich, MD, PhD (1)  ·  Naftali Kaminski, MD (1)  ·  Stephen Wisniewski, PhD (1)  ·  Vasily Andrianov, MD (1)

Results publications

PMID 26153726, PMID 30138687

NIH funding

U01HL112707 (1)